[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Genedx Holdings Corp (WGS)

Genedx Holdings Corp (WGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,060,050
  • Shares Outstanding, K 29,688
  • Annual Sales, $ 427,540 K
  • Annual Income, $ -21,020 K
  • EBIT $ -66 M
  • EBITDA $ -41 M
  • 60-Month Beta 1.90
  • Price/Sales 4.56
  • Price/Cash Flow 28.63
  • Price/Book 7.66

Options Overview Details

View History
  • Implied Volatility 91.54% (-1.88%)
  • Historical Volatility 79.11%
  • IV Percentile 70%
  • IV Rank 47.34%
  • IV High 133.95% on 10/23/25
  • IV Low 53.41% on 08/28/25
  • Expected Move (DTE 7) 2.41 (3.66%)
  • Put/Call Vol Ratio 1.59
  • Today's Volume 375
  • Volume Avg (30-Day) 1,234
  • Put/Call OI Ratio 0.42
  • Today's Open Interest 19,882
  • Open Int (30-Day) 19,788
  • Expected Range 63.23 to 68.05

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.19
  • Number of Estimates 1
  • High Estimate $-0.19
  • Low Estimate $-0.19
  • Prior Year $0.50
  • Growth Rate Est. (year over year) -138.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
52.51 +25.00%
on 06/11/26
72.95 -10.02%
on 07/02/26
+11.32 (+20.84%)
since 06/10/26
3-Month
32.21 +103.79%
on 05/06/26
73.46 -10.65%
on 04/21/26
+6.02 (+10.10%)
since 04/10/26
52-Week
32.21 +103.79%
on 05/06/26
170.87 -61.58%
on 12/02/25
-21.27 (-24.47%)
since 07/10/25

Most Recent Stories

More News
WGS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

SAN DIEGO , July 10, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers of GeneDx Holdings Corp. (NASDAQ: WGS) common stock between April 16, 2025 and May...

WGS : 65.64 (-5.40%)
Robbins LLP Urges WGS Stockholders to Contact the Firm for Information About Leading the Shareholder Class Action Against GeneDx Holdings Corp.

San Diego, California--(Newsfile Corp. - July 9, 2026) - Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired GeneDx Holdings Corp....

WGS : 65.64 (-5.40%)
WGS Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in GeneDx Holdings Corp. Securities Lawsuit - Contact Levi & Korsinsky

GeneDx Promised Fabric Genomics Would "Transform Static Data Into Recurring Revenue" and "Unlock Software-Based Revenue Streams" — Instead, Investors Got a $31.2 Million Write-Off and a 49% Stock Collapse...

WGS : 65.64 (-5.40%)
WGS INVESTOR DEADLINE: GeneDx Holdings Investors with Substantial Losses Have Opportunity to Lead the GeneDx Class Action Lawsuit- HBSS

SAN FRANCISCO , July 9, 2026 /PRNewswire/ -- Hagens Berman (HBSS), a national leader in securities litigation, is actively investigating claims in a securities class action lawsuit against GeneDx...

WGS : 65.64 (-5.40%)
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 8, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors...

WGS : 65.64 (-5.40%)
GeneDx Holdings (WGS) Hit with Securities Class Action Following 49% Stock Collapse -- HBSS

SAN FRANCISCO , July 7, 2026 /PRNewswire/ -- Hagens Berman (HBSS), a national leader in securities litigation, is actively investigating claims in a securities class action lawsuit against GeneDx...

WGS : 65.64 (-5.40%)
WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit

NEW YORK , July 7, 2026 /PRNewswire/ --

WGS : 65.64 (-5.40%)
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 7, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors...

WGS : 65.64 (-5.40%)
WGS Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages WGS Investors with Losses to Contact the Firm

Did you buy WGS securities between April 16, 2025, and May 4, 2026?

WGS : 65.64 (-5.40%)
GeneDx Holdings Corp. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - WGS

LOS ANGELES , July 7, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against GeneDx Holdings Corp. ("GeneDx" or "the Company") (NASDAQ: WGS )  for violations...

WGS : 65.64 (-5.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn.

See More

Key Turning Points

3rd Resistance Point 77.88
2nd Resistance Point 74.51
1st Resistance Point 71.95
Last Price 65.64
1st Support Level 66.02
2nd Support Level 62.65
3rd Support Level 60.09

See More

52-Week High 170.87
Fibonacci 61.8% 117.90
Fibonacci 50% 101.54
Fibonacci 38.2% 85.18
Last Price 65.64
52-Week Low 32.21

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.